Exploring the conformations of nitric oxide synthase with fluorescence

被引:5
|
作者
Arnett, David C. [1 ]
Bailey, Sheila K. [2 ]
Johnson, Carey K. [2 ]
机构
[1] Northwestern Coll, Dept Chem, 101 7th St SW, Orange City, IA 51041 USA
[2] Univ Kansas, Dept Chem, 1251 Wescoe Dr, Lawrence, KS 66045 USA
来源
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
Nitric Oxide Synthase; Fluorescence; FRET; Single-Molecule; Conformational Dynamics; Review; INTRAPROTEIN ELECTRON-TRANSFER; LASER FLASH-PHOTOLYSIS; MAXIMUM-ENTROPY METHOD; OUTPUT STATE; CALMODULIN-BINDING; 2-DOMAIN CONSTRUCT; CRYSTAL-STRUCTURE; ENERGY-TRANSFER; DOMAIN; FMN;
D O I
10.2741/4694
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Multi-domain oxidoreductases are a family of enzymes that catalyze oxidation-reduction reactions through a series of electron transfers. Efficient electron transfer requires a sequence of protein conformations that position electron donor and acceptor domains in close proximity to each other so that electron transfer can occur efficiently. An example is mammalian nitric oxide synthase (NOS), which consists of an N-terminal oxygenase domain containing heme and a C-terminal reductase domain containing NADPH/FAD and FMN subdomains. We describe the use of time-resolved and single-molecule fluorescence to detect and characterize the conformations and conformational dynamics of the neuronal and endothelial isoforms of NOS. Fluorescence signals are provided by a fluorescent dye attached to the Ca2+-signaling protein calmodulin (CaM), which regulates NOS activity. Time-resolved fluorescence decays reveal the presence of at least four underlying conformational states that are differentiated by the extent of fluorescence quenching. Single-molecule fluorescence displays transitions between conformational states on the time scales of milliseconds to seconds. This review describes the type of information available by analysis of time-resolved and single-molecule fluorescence experiments.
引用
收藏
页码:2133 / 2145
页数:13
相关论文
共 50 条
  • [31] Nitric oxide synthase inhibitors
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1996, 1 (08) : 352 - 352
  • [32] Nitric oxide synthase inhibitors
    Lloyd, AW
    DRUG DISCOVERY TODAY, 2000, 5 (12) : 570 - 570
  • [33] The mitochondrial nitric oxide synthase
    Boveris, A
    FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 : S35 - S35
  • [34] Flavonoids and nitric oxide synthase
    Olszanecki, R
    Gebska, A
    Kozlovski, VI
    Gryglewski, RJ
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2002, 53 (04): : 571 - 584
  • [35] Mitochondrial nitric oxide synthase
    Ghafourifar, P
    Cadenas, E
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (04) : 190 - 195
  • [36] Mitochondrial nitric oxide synthase
    Ghafourifar, Pedram
    Sen, Chandan K.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 1072 - 1078
  • [37] Models for nitric oxide synthase
    Groves, JT
    Wang, CY
    FASEB JOURNAL, 1997, 11 (09): : A769 - A769
  • [38] Tetrahydrobiopterin in nitric oxide synthase
    Tejero, Jesus
    Stuehr, Dennis
    IUBMB LIFE, 2013, 65 (04) : 358 - 365
  • [39] Nitric oxide synthase in CHF
    Rauchhaus, M
    von Lanzenauer, SH
    Coats, AJS
    EUROPEAN HEART JOURNAL, 2000, 21 (10) : 856 - 857
  • [40] Nitric oxide synthase activity
    Frederiks, WM
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1996, 44 (11) : 1345 - 1345